로딩 중…
지수 로딩 중…
Beta Bionics, Inc.
BBNX· NASDAQ· Health Care· Health Care Equipment & Services
$13.35+4.05%
2026-08-03
Financials
Valuation Metrics
Beta Bionics, Inc.'s Market Cap is $595M. At end of 2025 it was $1.23B. Ranked #2728 of 3,112 in US market (top 88%), #1169 of 1,445 on NASDAQ (top 81%), #166 of 206 in Health Care Equipment & Services (top 81%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $595M | US#2,728/3,112 Sec#166/206 |
| Revenue | $119M | US#2,759/3,112 Sec#185/206 |
| Net Income | $-73M | US—/3,112 Sec—/206 |
| Total Assets | $292M | US#2,904/3,112 Sec#179/206 |
| Net Assets | $256M | US#2,626/3,112 Sec#157/206 |
| Value | ||
| P/B | 2.32x | US#1,377/3,112 Sec#73/206 |
| P/S | 5.00x | US#2,270/3,112 Sec#157/206 |
| FCF Yield | -10.32% | US—/3,112 Sec—/206 |
| Profitability | ||
| ROE | -28.46% | US#2,608/3,112 Sec#160/206 |
| ROA | -24.96% | US#2,827/3,112 Sec#184/206 |
| Op. Margin | -69.75% | US#2,791/3,112 Sec#194/206 |
| Revenue Growth | 37.76% | US#401/3,112 Sec#23/206 |
| Financial Health | ||
| Debt Ratio | 14.05% | US#164/3,112 Sec#11/206 |
| Total Debt | $7M | US#2,823/3,112 Sec#192/206 |
| FCF | $-61M | US#2,499/3,112 Sec#183/206 |
| Cash | $44M | US#2,630/3,112 Sec#174/206 |
| Current Ratio | 8.88x | US#280/3,112 Sec#17/206 |
| Performance | ||
| 1Y Return | -18.60% | US#2,550/3,112 Sec#167/206 |
| 1M Return | -20.35% | US#2,951/3,112 Sec#195/206 |
| From 52W High | -59.19% | US#2,933/3,112 Sec#194/206 |
| 1Y MDD | -71.24% | US#2,937/3,112 Sec#189/206 |
| Trading | ||
| Volume | 2,761,190 shares | US#678/3,112 Sec#41/206 |
| Trading Value | $37M | US#1,580/3,112 Sec#112/206 |
| Per Share | ||
| EPS | $-1.81 | US—/3,112 Sec—/206 |
| BPS | $7.10 | US#2,032/3,112 Sec#121/206 |